Professional Acne Treatment Market Research Report: By Acne Type (Inflammatory, Non-inflammatory), Treatment Type (Devices, Drugs), Professional Type (Dermatologists, Cosmeticians) - Global Industry Analysis and Demand Forecast to 2030

Market Overview

The global professional acne treatment market generated $6,298.9 million revenue in 2020, and it is expected to grow at a CAGR of 7.6% during 2020–2030. This growth is attributed to the rising incidence of acne, growing disposable income in developed and developing countries, rising healthcare spending, and surging number of research programs.

During the COVID-19 pandemic, lockdowns have affected the whole world. Due to this, there has been a negative impact on the product sales and supply chains of numerous sectors, particularly during the first two quarters of the year 2020. This has adversely affected the trade of acne treatment products due to the reduced demand, constraints in the handling and transportation of goods, and widespread financial distress. In addition, the COVID-19 situation forced thousands of companies to shut down their assembly and manufacturing plants temporarily, thus leading to decreased raw material and component supply for acne treatment product manufacturing, thereby resulting in reduced sales.

Inflammatory Acne Type Held Larger Share due to Requirement for Immediate Treatment

Inflammatory acne held the larger share in 2020 in the professional acne treatment market, based on acne type. This is majorly attributed to the immediate requirement for effective treatment because it is generally painful. Furthermore, the commonly available salicylic acid and benzoyl-peroxide-based over-the-counter (OTC) products are not fully effective on inflammatory acne. Therefore, branded and generic drugs are offered by major pharmaceutical companies, on prescription, for inflammatory acne.

Devices To Witness Faster Growth due to Growing Adoption of Laser-Based treatments

The devices category is expected to witness the faster growth in the professional acne treatment market during the forecast period (2021–2030), based on treatment type. This will primarily be due to the rising adoption of laser- and light-based acne treatments, mainly in developed economies, owing to the side-effects of drugs.

Dermatologists To Lead Market due to Their Vast Knowledge and Skills

The dermatologists category is expected to lead the professional acne treatment market during the forecast period, based on professional type. This is attributed to the increasing number of skilled dermatologists treating skin diseases, including acne. Additionally, patients prefer dermatologists because of their extensive expertise and experience in dealing with the problem.

North America To Lead Market due to Increasing Acne Incidence and High Per Capita Income

North America dominated the market during the historical period (2014–2020) due to the rising incidence of acne, increasing awareness on newly developed drugs, large pipeline of drugs, and high per capita income in the region. Moreover, the region is marked by the presence of prominent dermatology drug manufacturers, such as Johnson & Johnson, Bausch Health Companies Inc., and Pfizer Inc., who provide numerous classes of drugs to the North American population.

Products Launches and Research and Development (R&D) Key Market Trends

Many pharmaceutical companies are launching novel products, which have become a major trend in the market for professional acne treatment products. For instance, in August 2020, Cassiopea SpA received the U.S. Food and Drug Administration (FDA) approval for Winlevi, a clascoterone-based cream designed for the treatment of acne in patients 12 years and older. Moreover, AnnJi Pharmaceutical Co. Ltd. is engaged in the development of AJ101, which is a topical cream formulation for the treatment of acne vulgaris. The active ingredient in AJ101 is a novel androgen receptor degradation enhancer, which effectively decreases the level of activity of the androgen receptor, mediated by the ubiquitin–proteasome system through the activation of the Nrf1 pathway.

Rising Adoption of Professional Acne Treatments Key Driver for Market

People are focusing on enhancing their appearance by actively investing in a comprehensive skincare regimen for acne, scars, and other skin problems. There are various treatment options available, such as topical therapies, systemic agents, physical modalities, lasers, and photodynamic therapy. Moreover, to permanently minimize the occurrence of acne, clinicians suggest the use of combination therapies, such as those involving a topical antibiotic and a retinoid, which, in turn, is having a positive influence on the market.

Increasing Prevalence of Acne also Helping Market Advance

The adolescent and young adult populations are highly prone to acne, which leads to a high volume of dermatologist and cosmetician consultations. Acne vulgaris is one of the most-prevalent dermatological disorders, affecting majority of the world's population at some point during their lives. For instance, according to the American Academy of Dermatology (AAD), acne affects 50 million people annually in the U.S., while as per the Global Health Data Exchange (GHDX), the prevalence of acne was 2.3 million people in Italy, 1.8 million in Spain, and 3.7 million in Germany in 2019. This strengthens the use of curative drugs and devices worldwide, thereby boosting the market revenue.

Explore more about this report - Request free sample

Market Players Involved in Product Launches to Gain Significant Position

The professional acne treatment market is fragmented in nature with the presence of several key players. Some of the major players in the industry are Galderma SA, Johnson & Johnson, Bausch Health Companies Inc., Pfizer Inc., CHEPLAPHARM Arzneimittel GmbH, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Bayer AG, Perrigo Company plc, Almirall S.A., Lumenis Ltd., Candela Corporation, Alma Lasers Ltd., Cutera Inc., Sciton Inc., EL.EN. S.p.a., Fotona d.o.o., Venus Concept Inc., Erchonia Corporation, and InMode Ltd.

In recent years, players in the global professional acne treatment market have been involved in product launches in order to attain a significant position. For instance:

• In April 2021, Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., launched the generic version of Absorica (isotretinoin) capsules in 10-mg, 20-mg, 25-mg, 30-mg, 35-mg, and 40-mg dose strengths. These can be used for the treatment of severe recalcitrant nodular acne in non-pregnant patients of 12 years of age and above with multiple inflammatory nodules with a diameter of 5 mm or greater.
• In February 2021, VYNE Therapeutics Inc., a specialty pharmaceutical company, announced that its AMZEEQ (minocycline) topical foam (4%) has received the approval of the FDA. AMZEEQ is indicated for the treatment of inflammatory lesions caused by non-nodular moderate-to-severe acne in adults and pediatric patients aged nine years or more.

Key Players in Global Professional Acne Market Include:

Market Size Breakdown by Segment

The global professional acne treatment market report offers comprehensive market segmentation analysis along with market estimation for the period 2014–2030.

Based on Acne Type

• Inflammatory
• Non-inflammatory

Based on Treatment Type

• Devices
  • Laser (Nd:YAG; Er:YAG, and Diode)
  • Intense pulsed light (IPL)
  • Photopneumatic
  • Radiofrequency
  • Low-level laser (light) therapy (LLLT), electroporation (ELP), and others (photodynamic, pulsed dye laser, potassium titanyl phosphate laser, infrared laser, and ultrasound)
• Drugs
  • Retinoids
  • Antibiotics
  • Hormonal agents
  • Combinations

Based on Professional Type

• Dermatologists
• Cosmeticians

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe
  • Austria
  • Belgium
  • Denmark
  • France
  • Germany
  •  Italy
  • Netherlands
  • Spain
  • Sweden
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea